Trials / Completed
CompletedNCT05757453
Boost Study 31380 (mHealth)
BoostOne Study (MHealth)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- NXTech · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to examine the potential for a new software-based behavioral support approach, for individuals with opioid use disorder, as an addition to usual care.
Detailed description
The purpose of this study is to examine the potential for a novel computer-based approach to mitigate the symptoms of opioid use disorder as part of a comprehensive treatment program. The study is designed as a single-arm field-test of cognitive training for individuals under supervised medical treatment for opioid use disorder. A custom and proprietary smartphone package (mHealth platform) comprises the intervention available to enrolled subjects for interaction over the study period. Commercial mobile devices serve as information presentation and data recording instruments. Additional outcome measures incorporate subject-reported data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | mHealth | Mobile platform |
Timeline
- Start date
- 2022-04-18
- Primary completion
- 2023-03-30
- Completion
- 2023-03-30
- First posted
- 2023-03-07
- Last updated
- 2024-12-18
- Results posted
- 2024-12-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05757453. Inclusion in this directory is not an endorsement.